A Case Report of Tyrosine Kinase Inhibitor Interruption in a Patient with Multilineage Philadelphia-Positive Acute Lymphoblastic Leukemia

Acta Haematologica · Published 2026-03-31 · DOI 10.1159/000551699

Authors being retrieved — see the publisher record. https://doi.org/10.1159/000551699

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Treatment of adult acute lymphoblastic leukemia—a therapeutic revolution in the making · Blood Cancer Journal · 2026 · Cites or is cited by this article
Future Directions in Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia · Acta Haematologica · 2025 · Same journal
Establishment and Evaluation of Prognostic Prediction Model for Diffuse Large B-Cell Lymphoma Patients Based on International Prognostic Index and FAT4, TP53 Mutation · Acta Haematologica · 2025 · Same journal
Increased Prevalence of Thromboembolic Events in Patients with Congenital Dyserythropoietic Anemia Type I · Acta Haematologica · 2025 · Same journal
Acta Haematologica in the Era of Artificial Intelligence · Acta Haematologica · 2026 · Same journal
Diagnostic Pathways and Procedural Risk in Primary Central Nervous System Lymphoma: A Nationwide Analysis · Acta Haematologica · 2026 · Same journal
Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection · Acta Haematologica · 2026 · Same journal
Hans-Based Cell of Origin Is Not of Prognostic Significance in Diffuse Large B-Cell Lymphoma Patients: A Retrospective Single-Center Study Conducted in 326 RCHOP-Treated Patients · Acta Haematologica · 2025 · Same journal
First Comprehensive Characterization of Lip Lymphoma: A Population-Based Study · Acta Haematologica · 2026 · Same journal
International Prognostic Scoring System, Revised International Prognostic Scoring System, and Molecular International Prognostic Scoring System Had No Identical Prognostic Power Depending on Treatment in Myelodysplastic Syndromes · Acta Haematologica · 2026 · Same journal